1 |
Yang CY, Song HS. Bee Venom Inhibits Prostate Cancer Growth in LNCaP Xenografts via Apoptosis. J Pharmacopuncture. 2010 ; 13(1) : 15-35.
|
2 |
Shin JM, Song HS. Bee Venom Inhibits DU-145 Human Prostate Cancer Cell Growth Through Inactivation of NF-. J Korean Acupuncture & Moxibustion Society. 2011 ; 28(3) : 101-10.
|
3 |
Oh HJ, Song HS. Bee Venom Inhibits PC-3 Cell Proliferation Through Induction of Apoptosis Via Inactivation of NF-. J Korean Acupuncture & Moxibustion Society. 2010 ; 27(3) : 1-13.
|
4 |
Hur KY, Song HS. Bee Venom Inhibits DU-145 Cell Proliferation Through Induction of Apoptosis. J Korean Acupuncture & Moxibustion Society. 2011 ; 28(3) : 111-9.
|
5 |
Woo JH, Kang JY, Kim EK et al. The effect of short term dutasteride therapy on microvessel density in benign prostatic hyperplasia. Korean J Urol. 2008 ; 49(6) : 515-9.
DOI
ScienceOn
|
6 |
Lourenco T, Pcickard R, Vale L et al. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ. 2008 ; 337 : a1662.
DOI
|
7 |
Doo HK. Donguisingyehagyeongu. Seoul : Kyung Hee University Press. 1994 : 359.
|
8 |
Jin S. Taepyeonghyeminhwajegugbang. Taipei : Seonpung Publisher. 1984 : 175.
|
9 |
Heo J. Donguibogam. Seoul : Donguibogam. 2010 :
|
10 |
Professors of Department of Formula Science in College of Korean Medicine. Formula Science. Seoul : Yeongnimsa. 1999 : 497.
|
11 |
Committee on Compilation of Textbook of Korean Society for Acupuncture & Moxibustion. Acupuncture & Moxibustion. Paju : Jipmoondang Publishing Company. 2008 : 306.
|
12 |
Rim HK, Rim JS, Moon HB. A Study on the Relationship between Histologic Composition and Clinical Symptoms in Benign Prostatic Hyperplasia. Korean J Urol. 1994 ; 35(3) : 230-6.
|
13 |
McNeal JE. The prostate and prostatic urethra: a morphologic synthesis. J Urol. 1972 ; 107(6) : 1008-16.
|
14 |
McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol. 1978 ; 15(4) : 340-5.
|
15 |
Kim JG, Cho KS, Ahn HJ. The Evaluation of Correlation between the Histologic Composition of BPH and TRUS Findings. Korean J Urol. 1998 ; 39(1) : 51-6.
|
16 |
Jung SI, Oh BR, Ryu SB. Assessing the Effect of Finasteride by Prostate Tissue Composition. Korean J Urol. 2001 ; 42(12) : 1278-83.
|
17 |
Chae SJ, Song HS. The Effects of Cobrotoxin on NF- Activation in Human Prostatic Cancer Cell Line(PC-3). J Korean Acupuncture & Moxibustion Medicine Society. 2005 ; 22(5) : 37-48.
|
18 |
Korean Society for Sexual Medicine and Andrology. Textbook of Andrology. Seoul : Koonja. 2003 ; 542, 557-65.
|
19 |
Hong SJ. Benign prostatic hyperplasia: Multiple factors for prostate tissue change with aging. Korean J Urol. 2005 ; 46(6) : 547-54.
|
20 |
Lee DH, Lee JS, Kim YS. The effects of Lygodium japonicum on experimental rat model of benign prostatic hyperplasia. J Korean Orient Int Med. 2010 ; 31(3) : 457-66.
|
21 |
Wei J, Calhoun E, Jacobsen S. Urologic disease in America project: benign prostatic hyperplasia. J Urol. 2005 ; 173(4) : 1256-61.
DOI
ScienceOn
|
22 |
Paloma AM, Clemens B, Angelika R et al. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. PNAS. 2009 ; 106(8) : 2859-63.
DOI
ScienceOn
|
23 |
Carson C III, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003 ; 61(4 Supple 1) : 2-7.
|
24 |
Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5 alphareductase inhibition in human benign prostatic hyperplasia. World J Urol. 2002 ; 19(6) : 413-25.
DOI
ScienceOn
|
25 |
McConnell J, Roehrborn C, Bautista O et al. Benign prostatic hyperplasia: maintaining symptom control and reducing complications. Urology. 2003 ; 62(3 Supple 1) : 15-23.
|
26 |
Lee HG, Park YI, Jo SR. Clinical results of transurethral Electro-Vaporization of the prostate. Korean J Urol. 2001 ; 42(8) : 804-8.
|
27 |
Amy E Krambeck, Shelly E Handa, James E Lingeman. Experience with more than 1,000 Holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2013 ; 189(4) : 1415-20.
DOI
ScienceOn
|
28 |
Doo HK. Donguisingyehag. Seoul : Seongbosa. 2003 : 705-8.
|
29 |
Doo HK. Imsangsingyehagyeongu. Seoul : Seongbosa. 1995 : 452.
|
30 |
Hyun MK, Sin WY, Choi EY et al. A case of intractable hiccup treated with Paljung-san. J Korean Orient Int Med. 2005 ; 25(2) : 506-11.
|
31 |
Kim SM, Yoo DY. A case report of the effect of Paljeongsna on the female urethral syndrome. Korean J Obstet Gynecol. 2007 ; 20(4) : 225-33.
|
32 |
Song MK, Park SH, Kang JS et al. Report of four cases of Paljung-san on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Korean Oriental Med. 2010 ; 31(1) : 153-61.
|
33 |
AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). chapter 1: Diagnosis and treatment recommendations. J Urol. 2003 ; 170 : 530-47
DOI
ScienceOn
|
34 |
Lim CY, Kim MH, Lee GS et al. Beneficial effect of Paljeong-san pharmacopuncture treatment combined with peritoneal injection on Glycerolinduced acute renal failure in rabbits. J Korean Pharm Sci. 2010 ; 13(3) : 73-80.
|
35 |
Lee SY, Kim MH, Cho SI et al. The effect of Paljeong-San pharmacopuncture treatment on Glycerol-induced acute renal failure in rats. The Journal of Daejeon Oriental Medicine. 2012 ; 21(1) : 163-74.
|
36 |
American Urological Association. American Urological Association Guideline: Management of Benign Prostatic Hyperplasia(BPH). American Urology Association Education and Research, Inc. 2010 : 2-8.
|
37 |
The Korean Urological Association. The Urology. Seoul : Korea Medical Box Publisher. 2001 : 307-9.
|
38 |
Chung BH. Medical management for benign prostatic hyperplasia. Korean J Urol. 2007 ; 48(3) : 233-43.
DOI
ScienceOn
|